Clinical Trial

A Phase 3 Trial of JKN2401 Injection in COPD

Name: A Phase 3 Trial of JKN2401 Injection in COPD — clinical trial record (NCT07330310)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous JKN2401 Injection in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-29.

Trial Details

NCT Number	NCT07330310
Lead Sponsor	Joincare Pharmaceutical Group Industry Co., Ltd
Conditions	Chronic Obstructive Pulmonary Disease (COPD)
Enrollment	888 participants
Start Date	2026-03
Primary Completion	2027-09 (estimated)
Study Completion	2027-11 (estimated)
Updated on ClinicalTrials.gov	2026-01-14